Hospital and Community Antimicrobial Resistance
Effective surveillance of antimicrobial resistance (AMR) in acute and community settings informs strategies for infection prevention and control and antimicrobial stewardship (AMS).
Overview
Data on AMR in hospitals and the community (in general practice, community health services, aged care homes and other non-hospital settings) are collected via:
- Australian Group on Antimicrobial Resistance (AGAR)
- Australian Passive AMR Surveillance (APAS)
- National Alert System for Critical Antimicrobial Resistances (CARAlert).
Latest AURA Data
The APAS Data Explorer provides interactive access to data on the distribution of antimicrobial resistance (AMR) across Australia using map-based visualisations for 2023 and 2024 for key resistances.
The CARAlert Data Explorer provides interactive access to data on critical antimicrobial resistances (CARs) across Australia. You can track trends and customise your view.
Latest reports
These reports provide analyses of data on AMR in group A and group B Streptococcus, multidrug-resistant organisms, critical antimicrobial resistances and bloodstream infections from APAS, CARAlert and AGAR. They include implications for patient safety and delivery of health care.
